Arbutus Biopharma Corporation (ABUS)
USD 3.19
(-7.8%)
USD 3.19
(-7.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 18.14 Million | 39.01 Million | 10.98 Million | 6.91 Million | 6.01 Million | 5.9 Million |
| Cost of Revenue | 73.7 Million | 1.42 Million | 1.75 Million | 47.48 Million | 57.6 Million | 57.9 Million |
| Gross Profit | -55.55 Million | 37.59 Million | 9.23 Million | -40.56 Million | -51.59 Million | -52 Million |
| Operating Expenses | 22.54 Million | 102.24 Million | 82.63 Million | 64.18 Million | 77.35 Million | 76.1 Million |
| Selling, General and Administrative Expenses | 22.47 Million | 17.83 Million | 17.13 Million | 14.72 Million | 17.72 Million | 16 Million |
| Research and Development Expenses | 73.7 Million | 84.4 Million | 65.5 Million | 47.48 Million | 57.6 Million | 57.9 Million |
| Other Expenses | -73.63 Million | 2.23 Million | 1.87 Million | 1.97 Million | 2.02 Million | 7.3 Million |
| Cost and Expenses | 96.24 Million | 102.24 Million | 82.63 Million | 64.18 Million | 77.35 Million | 76.1 Million |
| Operating Income | -78.1 Million | -65.45 Million | -73.52 Million | -57.8 Million | -144.07 Million | -89.8 Million |
| Interest Expense | 459 Thousand | 1.72 Million | 2.85 Million | 4.01 Million | 2.1 Million | 200 Thousand |
| Income Tax Expense | - | 4.44 Million | 1.1 Million | 1.46 Million | -12.65 Million | -4.3 Million |
| Earnings before Tax | -72.84 Million | -65.01 Million | -76.24 Million | -63.74 Million | -166.37 Million | -61.4 Million |
| Net Income | -72.84 Million | -69.45 Million | -77.35 Million | -65.21 Million | -153.72 Million | -57.1 Million |
| Earnings Per Share Basic | -0.44 | -0.46 | -0.73 | -0.86 | -2.69 | -1.03 |
| Earnings Per Share Diluted | -0.44 | -0.46 | -0.73 | -0.86 | -2.69 | -1.03 |
| Weighted Average Shares Outstanding | 165.96 Million | 150.93 Million | 106.24 Million | 75.83 Million | 57.09 Million | 55.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 165.96 Million | 150.93 Million | 106.24 Million | 75.83 Million | 57.09 Million | 55.3 Million |
| Gross Margin | -3.06 | 0.96 | 0.84 | -5.87 | -8.58 | -8.81 |
| EBIT Margin | -3.91 | -1.56 | -6.51 | -8.26 | -14.90 | -10.73 |
| Profit Margin | -4.02 | -1.78 | -7.04 | -9.43 | -25.57 | -9.68 |
| EBITDA | -70.98 Million | -61.85 Million | -71.63 Million | -57.8 Million | -147.32 Million | -58.95 Million |
| Earnings Before Tax Margin | -4.31 | -1.68 | -6.69 | -8.36 | -23.97 | -15.22 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.72 Million | 1.53 Million | 2.14 Million | 18.14 Million | 4.65 Million | 4.65 Million |
| Cost of Revenue | 356 Thousand | 355 Thousand | 359 Thousand | 1.4 Million | 369 Thousand | 342 Thousand |
| Gross Profit | 1.37 Million | 1.17 Million | 1.78 Million | 16.73 Million | 4.28 Million | 4.3 Million |
| Operating Expenses | 22.74 Million | 20.36 Million | 22.3 Million | 94.77 Million | 26.21 Million | 23.67 Million |
| Selling, General and Administrative Expenses | 7.19 Million | 4.95 Million | 4.74 Million | - | 5.84 Million | 5.98 Million |
| Research and Development Expenses | 15.55 Million | 15.4 Million | 17.56 Million | - | 20.16 Million | 17.69 Million |
| Other Expenses | 211 Thousand | 180 Thousand | -409 Thousand | 69 Thousand | 205 Thousand | - |
| Cost and Expenses | 23.09 Million | 20.71 Million | 22.66 Million | 96.17 Million | 26.21 Million | 23.67 Million |
| Operating Income | -21.37 Million | -19.18 Million | -20.52 Million | -78.03 Million | -21.55 Million | -18.38 Million |
| Interest Expense | 34 Thousand | 44 Thousand | 44 Thousand | 459 Thousand | -46 Thousand | 171 Thousand |
| Income Tax Expense | -1.00 | -1.00 | 1.07 Million | -1.00 | -369 Thousand | 171 Thousand |
| Earnings before Tax | -19.79 Million | -17.87 Million | -19.31 Million | -72.84 Million | -20.1 Million | -17.09 Million |
| Net Income | -19.79 Million | -17.87 Million | -19.31 Million | -72.84 Million | -20.1 Million | -17.09 Million |
| Earnings Per Share Basic | -0.11 | -0.10 | -0.11 | - | -0.12 | -0.10 |
| Earnings Per Share Diluted | -0.11 | -0.10 | -0.11 | - | -0.12 | -0.10 |
| Weighted Average Shares Outstanding | 188.04 Million | 175.62 Million | 168.43 Million | 165.96 Million | 167.51 Million | 166.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 188.04 Million | 175.62 Million | 168.43 Million | 165.96 Million | 167.51 Million | 166.06 Million |
| Gross Margin | 0.79 | 0.77 | 0.83 | 0.92 | 0.92 | 0.93 |
| EBIT Margin | -12.18 | -12.29 | -9.40 | - | -4.63 | -3.70 |
| Profit Margin | -11.47 | -11.67 | -9.00 | -4.02 | -4.32 | -3.68 |
| EBITDA | -21.01 Million | -18.82 Million | -20.16 Million | - | -21.55 Million | -17.21 Million |
| Earnings Before Tax Margin | -12.38 | -12.52 | -9.57 | -4.30 | -4.63 | -3.95 |
C1V
300150
GROWINGTON
DIOS
KNOS
8194